Skip to main content
. 2017 Feb 21;11:364–370. doi: 10.1016/j.dib.2017.02.040
Subject area Biology
More specific subject area Autoimmune Genetics
Type of data Tables, Figures
How data was acquired Molecular phenotypes are determined from transcriptomic data (RNAseq, Microarray) derived from previously published sources[2], [3], [4]
Molecular pathways were analysed using GeneGo, Metacore.
Flow Cytometry data was acquired using Canto II (BD Biosciences) and Fortessa (BD Biosciences) instruments.
Data format Analyzed
Experimental factors Samples are from whole blood collected in to PAXgene tubes for RNA analysis. The source of samples were healthy controls and Multiple Sclerosis patients not on therapy from Australia and the United States.
Experimental features Gene expression in whole blood was interrogated by transcriptomic and RTPCR procedures to identify genes dysregulated in MS and correlated gene sets (mRNA level). Flow cytometry was used to identify immune cell subsets in which ZMIZ1 and RPS6 were most highly expressed (protein level).
Data source location Cohorts of MS patients and controls are from Sydney and Perth in Australia; and Miami and San Francisco in United States.
Data accessibility UCSF CIS Cohort Transcriptome Source Data is in RepositoryGSE41846(url:https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE41846)
ANZgene Transcriptome Source Data is in RepositoryGSE17048(url:https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE17048)